Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Kozarich John W
Over the trailing 90 days, Kozarich John W (Director at LIGAND PHARMACEUTICALS INC) traded $596K of stock (net selling $313K) in LGND, per 8 SEC Form 4 transactions.
- Role
- Director
- Companies
- LGND
- Window
- Trailing 90 days · 8 transactions · CIK 1223000
- Net activity
- −$313K ($141K bought · $455K sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| LGND | LIGAND PHARMACEUTICALS INC | 8 | $141K | $455K | −$313K |
Transactions (8)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-06-05 | LGND | Buy | 836 | $0 | Grant, award or other acquisition |
| 2026-06-05 | LGND | Buy | 2.9K | $0 | Grant, award or other acquisition |
| 2026-05-13 | LGND | Buy | 1.6K | $109K | Exercise or conversion of derivative security |
| 2026-05-13 | LGND | Sell | 1.6K | $352K | Open market or private sale |
| 2026-05-13 | LGND | Sell | 1.6K | $0 | Exercise or conversion of derivative security |
| 2026-05-12 | LGND | Sell | 459 | $0 | Exercise or conversion of derivative security |
| 2026-05-12 | LGND | Sell | 459 | $103K | Open market or private sale |
| 2026-05-12 | LGND | Buy | 459 | $32K | Exercise or conversion of derivative security |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Kozarich's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.